Monashee Investment Management’s Cidara Therapeutics CDTX Stock Holding History

Monashee Investment Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-369,099	Closed	-$3.97M	–	45
2024 Q3	$3.97M	Hold	369,099	–	–	0.43%	29
2024 Q2	$4.41M	Buy	369,099 +350,644	+1,900%	+$4.8M	0.57%	21
2024 Q1	$340K	Hold	18,455	–	–	0.04%	102
2023 Q4	$293K	Hold	18,455	–	–	0.05%	41
2023 Q3	$348K	Hold	18,455	–	–	0.15%	71
2023 Q2	$417K	Hold	18,455	–	–	0.1%	65
2023 Q1	$469K	Buy	+18,455	New	+$524K	0.13%	51
2022 Q4	–	Sell	-18,455	Closed	-$232K	–	47
2022 Q3	$232K	Buy	+18,455	New	+$255K	0.09%	50
2022 Q2	–	Sell	-18,455	Closed	-$307K	–	31
2022 Q1	$307K	Buy	+18,455	New	+$313K	0.09%	34
2021 Q4	–	Sell	-18,455	Closed	-$827K	–	63
2021 Q3	$827K	Buy	+18,455	New	+$701K	0.15%	123
2021 Q2	–	Sell	-18,455	Closed	-$982K	–	436
2021 Q1	$982K	Hold	18,455	–	–	0.15%	183
2020 Q4	$738K	Hold	18,455	–	–	0.1%	174
2020 Q3	$1.05M	Hold	18,455	–	–	0.23%	90
2020 Q2	$1.36M	Hold	18,455	–	–	0.2%	119
2020 Q1	$915K	Hold	18,455	–	–	0.49%	18
2019 Q4	$1.42M	Hold	18,455	–	–	1.32%	28
2019 Q3	$738K	Sell	18,455 -5,588	-23%	-$188K	0.34%	70
2019 Q2	$808K	Hold	24,043	–	–	0.21%	92
2019 Q1	$1.27M	Hold	24,043	–	–	0.29%	85
2018 Q4	$1.13M	Buy	+24,043	New	+$1.72M	0.77%	38
2018 Q3	–	Hold	0	–	–	–	57
2018 Q2	–	Hold	0	–	–	–	67

Other funds holding CDTX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Checkpoint Capital San Francisco, California $390M AUM 96.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Monashee Investment Management's CDTX Position: Q4 2024 in Review

Monashee Investment Management sold out of Cidara Therapeutics (CDTX) in Q4 2024, closing a stake of 369,099 shares — an estimated $3.97M sold.

Monashee Investment Management first reported a position in CDTX in Q4 2018 and held it in 20 quarters. The position peaked at $4.41M in Q2 2024. 40 funds tracked by Wall St. Rank hold CDTX as of Q4 2024.

Monashee Investment Management reported no remaining Cidara Therapeutics position as of Q4 2024 after selling out during the quarter.
Monashee Investment Management sold 369,099 Cidara Therapeutics shares in Q4 2024, an estimated $3.97M.
Monashee Investment Management first reported a position in Cidara Therapeutics in Q4 2018 and held it in 20 quarters.
Monashee Investment Management's Cidara Therapeutics position peaked at $4.41M in Q2 2024.
40 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2024.

Based on Monashee Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.